These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients. Alpermann T; Haferlach C; Eder C; Nadarajah N; Meggendorfer M; Kern W; Haferlach T; Schnittger S Leuk Res; 2015 Mar; 39(3):265-72. PubMed ID: 25592059 [TBL] [Abstract][Full Text] [Related]
8. Acute Myeloid Leukemia (AML): Upregulation of BAALC/MN1/MLLT11/EVI1 Gene Cluster Relate With Poor Overall Survival and a Possible Linkage With Coexpression of MYC/BCL2 Proteins. Akhter A; Farooq F; Elyamany G; Mughal MK; Rashid-Kolvear F; Shabani-Rad MT; Street L; Mansoor A Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):483-488. PubMed ID: 28362701 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Garzon R; Volinia S; Papaioannou D; Nicolet D; Kohlschmidt J; Yan PS; Mrózek K; Bucci D; Carroll AJ; Baer MR; Wetzler M; Carter TH; Powell BL; Kolitz JE; Moore JO; Eisfeld AK; Blachly JS; Blum W; Caligiuri MA; Stone RM; Marcucci G; Croce CM; Byrd JC; Bloomfield CD Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18679-84. PubMed ID: 25512507 [TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312 [TBL] [Abstract][Full Text] [Related]
11. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853 [TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathologic characterization of AML with isolated trisomy 4. Bains A; Lu G; Yao H; Luthra R; Medeiros LJ; Sargent RL Am J Clin Pathol; 2012 Mar; 137(3):387-94. PubMed ID: 22338050 [TBL] [Abstract][Full Text] [Related]
13. Comparison of gene mutation spectra in younger and older Chinese acute myeloid leukemia patients and its prognostic value. Zhong WJ; Liu XD; Zhong LY; Li KB; Sun QX; Xu X; Wei T; Li QS; Zhu ZG Gene; 2021 Feb; 770():145344. PubMed ID: 33333221 [TBL] [Abstract][Full Text] [Related]
14. The prognostic implication of SRSF2 mutations in Chinese patients with acute myeloid leukemia. Yang J; Yao DM; Ma JC; Yang L; Guo H; Wen XM; Xiao GF; Qian Z; Lin J; Qian J Tumour Biol; 2016 Aug; 37(8):10107-14. PubMed ID: 26820131 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study. Kawashima N; Akashi A; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kitamura K; Sakaida E; Takeshita A; Suzushima H; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H; Ann Hematol; 2019 Jan; 98(1):83-91. PubMed ID: 30251205 [TBL] [Abstract][Full Text] [Related]
16. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Rogers HJ; Wang X; Xie Y; Davis AR; Thakral B; Wang SA; Borthakur G; Cantu MD; Margolskee EM; Philip JKS; Sukhanova M; Bagg A; Bueso-Ramos CE; Orazi A; Arber DA; Hsi ED; Hasserjian RP Am J Hematol; 2020 Jul; 95(7):799-808. PubMed ID: 32249963 [TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. Dufour A; Schneider F; Metzeler KH; Hoster E; Schneider S; Zellmeier E; Benthaus T; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Hiddemann W; Bohlander SK; Spiekermann K J Clin Oncol; 2010 Feb; 28(4):570-7. PubMed ID: 20038735 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype. El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678 [TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448 [TBL] [Abstract][Full Text] [Related]
20. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Farag SS; Archer KJ; Mrózek K; Vardiman JW; Carroll AJ; Pettenati MJ; Moore JO; Kolitz JE; Mayer RJ; Stone RM; Larson RA; Bloomfield CD Int J Oncol; 2002 Nov; 21(5):1041-51. PubMed ID: 12370753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]